apocell Home Contact Us
  • CLINICAL TRIAL EXPERIENCE
    SPECIMENS ANALYZED
  • proposal request contact us
  • News

    February 4, 2010

    ApoCell Awarded Contract to Develop Circulating Tumor Cell Isolation Technology (ApoStreamTM) from NCI's Division of Cancer Treatment and Diagnosis (DCTD)

    June 1, 2011, Houston

    ApoCell Launches Revolutionary Circulating Cancer Cell Detection System - ApoStreamTM

    August 10, 2011, Houston

    ApoCell Awarded $2.9M from SAIC-Frederick, Inc. to Deliver a New Platform for Detection and Molecular Analysis of Circulating Tumor Cells

    August 24, 2011, Houston

    ApoCell named to Inc Magazine's List of the 5000 Fastest Growing Private Companies

    September 23, 2011, Houston

    ApoCell named to Houston Business Journal's List of the 100 Fastest-Growing Private Companies in Houston

    September 30, 2011, Houston

    ApoCell awarded SBIR Grant to Develop Point of Care Device for Antibody Independent Isolation of Circulating Tumor Cells

    November 11, 2011, Houston

    ApoCell Publishes Data Demonstrating the Improved CTC Capture Capabilities of the ApoStreamTM Device

    April 1, 2012, Houston

    ApoCell's CTC Capture Technology First To Reliably Detect and Recover Deadly Liver Cancer Cells

Illuminating biomarker detection – Leading the way in personalized medicine.

Personalized medicine is the wave of the future, and ApoCell is at the forefront of discovering and analyzing biomarkers that will make this new treatment revolution possible. We continually seek out individuals with exceptional credentials and experience to support our growth and our team. By working at ApoCell, you will have the opportunity to use cutting edge technology in a high growth environment, working with renowned thought leaders.

Employment Opportunities

Clinical Trials Logistics Coordinator
Executive Administrative Assistant
Post-Doctoral Scientist
Project Manager
Research Assistant